 |
市場調查報告書
商品編碼
1991415
全球組織處理系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）Global Tissue Processing System Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
預計組織處理系統市場將從 2025 年的 4.7393 億美元成長到 2034 年的 8.4314 億美元，2026 年至 2034 年的複合年成長率為 6.61%。
精準高效病理診斷日益成長的需求正推動全球組織處理系統市場穩定成長。組織處理系統是實驗室中必不可少的設備，用於製備生物組織樣本以供顯微鏡檢查。隨著癌症檢測和研發領域診斷程序的不斷增加，自動化組織處理技術正被廣泛應用於實驗室。實驗室自動化技術的進步和診斷流程的改進顯著促進了醫院和研究機構市場的發展。
多種因素正在推動組織處理系統市場的成長。全球癌症和其他慢性疾病發生率的不斷上升，推動了病理檢測需求的成長。醫院和診斷檢查室正在投資先進的系統，以縮短處理時間並改善檢體保存。此外，對醫學研究、生物技術和個人化醫療投入的增加，也加速了精密組織分析設備的應用。
隨著醫療系統不斷推動檢查室基礎設施現代化，組織處理系統市場前景依然光明。全自動和高通量系統的應用有望提高病理檢查室的效率並減少人為錯誤。新興經濟體也不斷提升診斷能力，進而創造新的成長機會。隨著精準醫療和先進疾病檢測技術的重要性日益凸顯，對可靠組織處理技術的需求預計將進一步成長。
目錄
第1章：引言
第2章執行摘要
第3章 市場變數、趨勢與框架
- 市場譜系展望
- 滲透率和成長前景分析
- 價值鏈分析
- 法律規範
- 標準與合規性
- 監管影響分析
- 市場動態
- 市場促進因素
- 市場限制因素
- 市場機遇
- 市場挑戰
- 波特五力分析
- PESTLE分析
第4章 全球組織處理系統市場：依產品類型分類
- 市場分析、洞察與預測
- 自動化組織處理設備
- 半自動組織處理設備
- 手動組織處理裝置
第5章 全球組織處理系統市場：依應用分類
- 市場分析、洞察與預測
- 組織病理學
- 細胞病理學
- 血液病理學
- 其他
第6章 全球組織處理系統市場：依最終使用者分類
- 市場分析、洞察與預測
- 醫院
- 診斷檢查室
- 研究機構
- 其他
第7章 全球組織處理系統市場：依地區分類
- 區域分析
- 北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
- 歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
- 拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
- 中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家
第8章 競爭情勢
- 最新趨勢
- 公司分類
- 供應鏈和銷售管道合作夥伴（根據現有資訊）
- 市場佔有率和市場定位分析（基於現有資訊）
- 供應商情況（基於現有資訊）
- 策略規劃
第9章：公司簡介
- 主要公司的市佔率分析
- 公司簡介
- Leica Biosystems
- Thermo Fisher Scientific Inc
- Sakura Finetek USA Inc
- Milestone Medical Technologies Inc
- BioGenex Laboratories
- Agilent Technologies Inc
- Merck KGaA
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers AG
- PerkinElmer Inc
The Tissue Processing System Market size is expected to reach USD 843.14 Million in 2034 from USD 473.93 Million (2025) growing at a CAGR of 6.61% during 2026-2034.
The global tissue processing system market has grown steadily due to increasing demand for accurate and efficient pathology diagnostics. Tissue processing systems are essential laboratory devices used to prepare biological tissue samples for microscopic examination. As the number of diagnostic procedures rises, particularly in cancer detection and research, laboratories are adopting automated tissue processing technologies. Advances in laboratory automation and improvements in diagnostic workflows have significantly contributed to the market's development across hospitals and research institutions.
Several factors are driving the growth of the tissue processing system market. The increasing global prevalence of cancer and other chronic diseases has created greater demand for pathology testing. Hospitals and diagnostic laboratories are investing in advanced systems that offer faster processing times and improved sample preservation. In addition, growing investments in medical research, biotechnology, and personalized medicine are encouraging the use of advanced tissue analysis equipment.
The future outlook for the tissue processing system market remains positive as healthcare systems continue to modernize laboratory infrastructure. The adoption of fully automated and high-throughput systems is expected to improve efficiency and reduce manual errors in pathology laboratories. Emerging economies are also expanding their diagnostic capabilities, creating new growth opportunities. As precision medicine and advanced disease detection methods gain importance, demand for reliable tissue processing technologies is likely to increase further.
MARKET SEGMENTATION
By Product Type
- Automated Tissue Processors
- Semi-Automated Tissue Processors
- Manual Tissue Processors
By Application
- Histopathology
- Cytopathology
- Hematopathology
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
COMPANIES PROFILED
- Leica Biosystems, Thermo Fisher Scientific Inc, Sakura Finetek USA Inc, Milestone Medical Technologies Inc, BioGenex Laboratories, Agilent Technologies Inc, Merck KGaA, Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, PerkinElmer Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Automated Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Semi-Automated Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Manual Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Histopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cytopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Hematopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY END USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End User
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End User
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End User
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End User
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End User
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End User
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL TISSUE PROCESSING SYSTEM INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Leica Biosystems
- 9.2.2 Thermo Fisher Scientific Inc
- 9.2.3 Sakura Finetek USA Inc
- 9.2.4 Milestone Medical Technologies Inc
- 9.2.5 BioGenex Laboratories
- 9.2.6 Agilent Technologies Inc
- 9.2.7 Merck KGaA
- 9.2.8 Danaher Corporation
- 9.2.9 Roche Diagnostics
- 9.2.10 Siemens Healthineers AG
- 9.2.11 PerkinElmer Inc
